Analgesics (Pharmacies) - United States

Revenue in the Analgesics market is projected to reach US$4.52bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 4.47%, resulting in a market volume of US$5.62bn by 2029.
In global comparison, most revenue will be generated China (US$5.03bn in 2024).
In relation to total population figures, per person revenues of US$13.22 are generated in 2024.

Definition:
The Analgesics market encompasses non-prescription natural and synthetic non-opioid analgesics sold through pharmacies. These include well-known products such as Paracetamol, Ibuprofen, Aspirin, Diclofenac, and various pain-relieving preparations. The market's scope varies with national legislation concerning opioid analgesics, with legal opioids being incorporated based on respective state regulations. In countries like Germany, Austria, and Switzerland, opioid analgesics are included if they comply with narcotics law limitations and do not necessitate a prescription. The analgesics are presented in forms like pills, capsules, gels, and ointments. However, the market excludes prescription medications (e.g., morphine), anesthetics, and homeopathic remedies. Notable top-selling painkillers encompass Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol, and ASS. This market exclusively covers product sales through pharmacies.

Additional information:
The Analgesics market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
Natural and synthetic agents
In the form of pills, capsules, gels and ointments

Prescription medicines
Homeopathic remedies
Anesthetics

The Analgesics (Pharmacies) market in United States has been experiencing significant growth in recent years.

Customer preferences: Customers in the United States have shown a strong preference for analgesics purchased from pharmacies. This can be attributed to the convenience and accessibility of pharmacies, as well as the trust that customers have in the quality and efficacy of the products sold in these establishments. Additionally, pharmacies often provide additional services such as consultations with pharmacists, which further enhance the customer experience.

Trends in the market: One of the key trends in the Analgesics (Pharmacies) market in United States is the increasing demand for over-the-counter (OTC) analgesics. This can be attributed to several factors, including the rising prevalence of chronic pain conditions, the aging population, and the growing awareness and acceptance of self-medication practices. OTC analgesics offer a convenient and cost-effective solution for individuals seeking relief from mild to moderate pain without the need for a prescription. Another trend in the market is the growing popularity of natural and herbal analgesics. Consumers in the United States are becoming more health-conscious and are seeking alternative treatment options that are perceived to be safer and have fewer side effects. As a result, there has been an increase in the demand for analgesics derived from natural sources such as plants and herbs.

Local special circumstances: The United States has a well-established healthcare system, which includes a large number of pharmacies across the country. These pharmacies serve as a primary point of access for individuals seeking healthcare products, including analgesics. The presence of a vast network of pharmacies ensures that customers have easy access to a wide range of analgesics, thereby driving market growth.

Underlying macroeconomic factors: The growing demand for analgesics in the United States can also be attributed to underlying macroeconomic factors. The country has a high prevalence of chronic pain conditions, such as arthritis and back pain, which drive the need for pain relief medications. Additionally, the aging population in the United States is increasing, leading to a higher demand for analgesics to manage age-related pain and discomfort. Furthermore, the United States has a high disposable income and a strong consumer culture, which enables individuals to afford and purchase analgesics. The availability of various payment options, such as insurance coverage and flexible spending accounts, further facilitates the purchase of analgesics. In conclusion, the Analgesics (Pharmacies) market in United States is experiencing growth due to customer preferences for pharmacy purchases, the increasing demand for OTC analgesics, the popularity of natural and herbal analgesics, the presence of a large number of pharmacies, the high prevalence of chronic pain conditions, the aging population, and the strong macroeconomic factors in the country.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.